MO on NYSE

Altria

Logo: Unknown author Unknown author, Public domain, via Wikimedia Commons5

American tobacco corporation

Altria Group, Inc. is an American corporation and one of the world's largest producers and marketers of tobacco, cigarettes, and medical products in the treatment of illnesses caused by tobacco.3 From Wikipedia, CC BY-SA 4.0

$73.70 up 0.57 (0.78%)Price as of Oct 15, 2026 at 19:45 UTC

Last updated Oct 16, 2026.

Overview

1985Founded1

Compare with Philip Morris International, RLX Technology Inc. or Ispire Technology Inc., or pick any stock.

  • TickerMO on NYSE1
  • Industryfood industry, tobacco industry1
  • HeadquartersRichmond1
  • Founded inLondon1
  • Websitewww.altria.com
  • Incorporated inVA6
  • Business address6601 West Broad Street, Richmond, Va 232306
  • Filer categoryLarge accelerated filer6
Altria Building (8156028882)
Photo: Eden, Janine and Jim from New York City, CC BY 2.0, via Wikimedia Commons8

Altria Group, Inc. is an American corporation and one of the world's largest producers and marketers of tobacco, cigarettes, and medical products in the treatment of illnesses caused by tobacco. It operates worldwide and is headquartered in the city of Richmond, Virginia.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

62.5%Gross margin9
42.5%Operating margin9
29.8%Net margin9
-3.1%Revenue growth, 20259
$9.1BFree cash flow9

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Smokeable Products brought in 88% of the revenue Altria broke down this way in fiscal 2025.

  1. Smokeable Products$20.5B988%down 3% from 2024
  2. Oral Tobacco$2.8B912%up 1% from 2024
  3. Other Operating$5.0M90%up 350% from 2024
Business segments by year
Business segments202320242025
Smokeable Products$21.8B$21.2B$20.5B
Oral Tobacco$2.7B$2.8B$2.8B
Other Operating-$2.0M-$2.0M$5.0M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue24¢$5.6B
  • Research and development1¢$195.0M
  • Other costs35¢$8.1B
  • Income tax10¢$2.4B
  • Profit30¢$6.9B

Out of $23.3B in revenue.9

Where each dollar of operating cash went, fiscal 2025

  • Capital spending2¢$216.0M
  • Dividends paid75¢$7.0B
  • Share buybacks11¢$1.0B
  • Kept or used elsewhere12¢$1.1B

Out of $9.3B of cash from operations.9

Financial statements

Revenue101112139$23.3B in 2025−7% since 2019
0$10.0B$20.0B$30.0B2019: $25.1B$25.1B20192020: $26.2B$26.2B2020+4%2021: $26.0B$26.0B2021−1%2022: $25.1B$25.1B2022−4%2023: $24.5B$24.5B2023−2%2024: $24.0B$24.0B2024−2%2025: $23.3B$23.3B2025−3%
Gross profit101112139$14.5B in 2025+14% since 2019
0$5.0B$10.0B$15.0B2019: $12.7B$12.7B20192020: $13.0B$13.0B2020+2%2021: $14.0B$14.0B2021+7%2022: $14.2B$14.2B2022+2%2023: $14.3B$14.3B2023+0%2024: $14.4B$14.4B2024+1%2025: $14.5B$14.5B2025+1%
Operating income101112139$9.9B in 2025−4% since 2019
0$5.0B$10.0B$15.0B2019: $10.3B$10.3B20192020: $10.9B$10.9B2020+5%2021: $11.6B$11.6B2021+6%2022: $11.9B$11.9B2022+3%2023: $11.5B$11.5B2023−3%2024: $11.2B$11.2B2024−3%2025: $9.9B$9.9B2025−12%
Net income101112139$6.9B in 2025
-$5.0B0$5.0B$10.0B$15.0B2019: -$1.3B-$1.3B20192020: $4.5B$4.5B20202021: $2.5B$2.5B2021−45%2022: $5.8B$5.8B2022+133%2023: $8.1B$8.1B2023+41%2024: $11.3B$11.3B2024+39%2025: $6.9B$6.9B2025−38%

Every line of the income statement in the latest annual report, as filed.9

Period ending2025-12-312024-12-312023-12-31
Net revenues$23.3B$24.0B$24.5B
Cost of sales$5.6B$6.1B$6.2B
Excise taxes on products$3.1B$3.6B$4.0B
Gross profit$14.5B$14.4B$14.3B
Marketing, administration and research costs$2.5B$2.7B$2.7B
Asset impairment and exit costs, net of cash paid$978.0M$389.0M$0
Impairment of goodwill$1.2B$0$0
Operating income$9.9B$11.2B$11.5B
Interest and other debt expense, net$1.1B$1.0B$989.0M
Net periodic benefit income, excluding service cost-$59.0M-$102.0M-$127.0M
(Income) losses from investments in equity securities-$510.0M-$652.0M-$243.0M
Gain on the sale of IQOS System commercialization rights$0-$2.7B$0
Earnings before income taxes$9.4B$13.7B$10.9B
Provision for income taxes$2.4B$2.4B$2.8B
Net earnings$6.9B$11.3B$8.1B
Basic earnings per share attributable to Altria (in usd per share)$4.12$6.54$4.57
Diluted earnings per share attributable to Altria (in usd per share)$4.12$6.54$4.57

Compare Altria with another company

The story

Founded by Kraft Foods Group, Nabisco and Philip Morris USA in 1985, in London.1

Altria emerged from Philip Morris USA. The onset of "rebranding" of Philip Morris Companies to Altria took place in 2003 (Philip Morris would later split, with Philip Morris USA remaining Altria's primary and only consistently held asset). According to Altria, it was created because Philip Morris wished to emphasize that its business portfolio had come to consist of more than Philip Morris USA and Philip Morris International; at the time, it owned an 84% stake in Kraft Foods, although that business has since been spun off. The name "Altria" is claimed to come from the Latin word for "high" and was part of a trend of companies rebranding to names that previously did not exist, Accenture (previously Andersen Consulting) and Verizon being notable examples, though linguist Steven Pinker suggests that in fact the name is an "egregious example" of phonesthesia—with the company attempting to "switch its image from bad people who sell addictive carcinogens to a place or state marked by altruism and other lofty values".

The company's branding consultants, the Wirthlin Group, said: "The name change alternative offers the possibility of masking the negatives associated with the tobacco business", thus enabling the company to improve its image and raise its profile without sacrificing tobacco profits. Philip Morris executives thought a name change would insulate the larger corporation and its other operating companies from the political pressures on tobacco.

The rebranding took place amidst social, legal, and financially troubled circumstances. In 2003 Altria was ranked Fortune number 11, and has steadily declined since. In 2010 Altria Group (MO) ranked at Fortune number 137, whereas its former asset, Philip Morris International, was ranked 94th.

In 2006, a United States court found that Philip Morris "publicly... disputed scientific findings linking smoking and disease knowing their assertions were false." In a 2006 ruling, a federal court found that Altria, along with R. J. Reynolds, Lorillard and Philip Morris were found guilty of misleading the public about the dangers of smoking. Within this ruling, it was noted that "defendants altered the chemical form of nicotine delivered in mainstream cigarette smoke for the purpose of improving nicotine transfer efficiency and increasing the speed with which nicotine is absorbed by smokers." This was done by manipulating smoke pH with ammonia. Adding ammonia increases the smoke pH, in a process called "freebasing" which causes smokers to be "exposed to higher internal nicotine doses and become more addicted to the product."

On March 30, 2007, Altria's 88.1% stake in Kraft Foods was spun off, through a distribution of the remaining stake of shares (88.1%) to Altria shareholders. That same year, Altria began selling all its shares of Philip Morris International to Altria stockholders, a spin-off that was completed on March 28, 2008. Again in 2007 the company began the acquisition of cigar manufacturer John Middleton Co. from Bradford Holdings, which was complete in 2008. After Philip Morris International spun off, the former international subsidiaries halted the purchase of tobacco from America, which was a major factor in the closing of a newly renovated plant in North Carolina, an approximately 50% reduction in manufacturing, large-scale layoffs, and induced early retirements.

In 2008, Altria officially moved its headquarters from New York City to Richmond, Virginia, after Philip Morris sold its downtown offices in New York City a decade earlier. With a few exceptions, all manufacturing, commercial, and executive employees had long been based in and around Richmond. The company is now headquartered in an unincorporated area within Henrico County, less than five miles (8.0 km) west of the city limits of Richmond and less than 10 miles (16 km) from its downtown Richmond campus.

Aside from the Philip Morris/Altria headquarters, some of their other buildings included the Altria Center for Research and Technology in downtown Richmond, their manufacturing center in South Richmond, and the adjacent operations center which began shutting down in 2007–2008, as a result of the loss of demand from Philip Morris International member companies. The layoffs beginning in 2007 affected thousands of Altria, Altria Client Services, Philip Morris USA, and contracted employees in Richmond and North Carolina.

In 2009, Altria finalized its purchase of UST Inc., whose products included smokeless tobacco (made by U.S. Smokeless Tobacco Company) and wine (made by Chateau Ste. Michelle). This ended a short era of competition between the new Marlboro smokeless tobacco products such as snus, and those produced by UST Inc.

Read the full text

On December 8, 2018, Altria announced its intent to acquire a 45% stake in Cronos Group for $1.8 billion.

On December 20, 2018, Altria finalized the acquisition of a 35% stake in JUUL Labs, an e-cigarette company based out of San Francisco, California, for $12.8 billion. On November 3, 2019, it was reported that Altria was taking a $4.5 billion writedown on its stake in Juul, 35% of its original value. On July 28, 2022, it was reported that Altria's investment in Juul is now worth only 5% of the original amount of $12.8 billion. Despite the losses, Altria has announced that it will continue to support Juul and avoid investing in competing products.

Altria is taking a stake in the global business of Swiss tobacco company Burger Söhne (Helix Innovations with the On! brand) for $372 million in June 2019.

Altria and Japan Tobacco announced a joint venture called Horizon Innovations LLC on October 27, 2022. Horizon, owned 75 percent by Altria and 25 percent by Japan Tobacco, intends to sell Ploom heated tobacco sticks in the United States. FDA approval was expected to take until 2025, with customers able to buy Ploom by 2027.

Altria completed the acquisition of NJOY Holdings, Inc. on June 1, 2023.

From Wikipedia’s article on Altria, shared under CC BY-SA 4.0.7

Leadership

Who has led Altria, and when. Pick a name to see everywhere that person has worked.

1990200020102020
Board members and other officers (10)

Products and brands

  • tobacco
  • tobacco product

Listed on Wikidata.1

Subsidiaries and ownership

Subsidiaries

Also owns

From Wikidata.1

Former names

  • ALTRIA GROUP INCJan 29, 2003 to Feb 7, 20066
  • PHILIP MORRIS COMPANIES INCApr 13, 1994 to Jan 2, 20036

Timeline

  1. Apr 16, 2020New chief executive William F. Gifford, Jr. becomes CEO1
  2. 1985Founded Founded in London1

Recent filings

  1. Oct 9, 20268-K
  2. Sep 11, 20264
  3. Sep 2, 20263
  4. Aug 28, 20268-K
  5. Jul 30, 20268-K
  6. Jul 30, 202610-Q
  7. Jun 5, 202611-K 2025 SALARIED DPS PLAN
  8. Jun 5, 202611-K 2025 HOURLY DPS PLAN
  9. May 28, 2026SD
  10. May 28, 20264
  11. May 28, 20264
  12. May 27, 202610-K/A
  13. May 26, 2026144
  14. May 26, 2026144/A
  15. May 26, 2026144

Every filing from the last three years, summarized. The full record is on SEC EDGAR.2